Effects of Cetoleic Acid on Atherosclerosis
Official title: Effects of Ketolic Acid on Atherosclerosis Markers in High-risk Patients With Metabolic Syndrome (Effekt av Ketolinsyre på aterosklerosemarkører i høyrisikopasienter Med Metabolsk Syndrom)
Run by Oslo University Hospital · NCT06172335 · Data updated 2026-11-12
This study is testing if taking cetoleic acid-rich oil can help improve heart health and lower risks for people with metabolic syndrome.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 70 Years |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Oslo University Hospital Academic / other |
| Locations | 1 site (Oslo) |
| Status | Recruiting |
| Started | January 3, 2024 |
| Main results expected | December 30, 2024 |
| Study ends | December 31, 2027 |
| Registry record updated | January 16, 2025 |
| Trial ID | NCT06172335 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are men and women aged 20-70 with triglycerides greater than 1.7 mmol/L and specific waist measurements indicating metabolic syndrome.
✕Probably not a fit
Patients with chronic diseases, ongoing cancer treatment, or those with high cholesterol levels will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the impact of cetoleic acid-rich oil on atherosclerosis in individuals with metabolic syndrome. Participants will be randomly assigned to receive either the cetoleic acid oil or a control oil with lower cetoleic acid but similar levels of EPA and DHA. The study will measure changes in plasma levels of EPA and DHA, as well as various atherosclerotic markers, glucose, c-peptide, and triglycerides over a four-week period. The trial aims to determine if cetoleic acid can improve metabolic health and cardiovascular risk factors.
Why it matters
Potential benefit: If successful, this study could lead to improved dietary interventions for preventing cardiovascular diseases in individuals with metabolic syndrome.
How similar studies have gone: Previous studies have shown promising results with omega-3 fatty acids in cardiovascular health, suggesting potential success for this novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Triglycerides \> 1.7 mmol/L * Waist measurement \> 80 cm (women) and \> 94 cm (men) Exclusion Criteria: * Chronic disease (liver/kidney/metabolism) * Ongoing active cancer treatment * Excessive alcohol consumption (\>40g/day) * Pregnant/breastfeeding or planned pregnancy during the intervention * High intake of fish (\>3 weekly meals) * Level of free thyroxine (T4) and triiodothyronine (T3) outside reference ranges. * Hypertension (≥ 160/ 100 mmHg) * Total cholesterol \> 7.8 mmol/L * Blood donation during the intervention period * Difficulty following the protocol * Smoking or sniffing * Regular use (\> 1 day/week) of anti-inflammatory drugs * Regular use of omega-3 supplements/cod liver oil * Drug use other than stable use of statins, hypertension drugs (Ca antagonists, diuretics and beta blockers). * Hormonal treatment excluding stable use of thyroxine and birth control pills/contraceptive rod
Where it's running
-
Oslo University Hospital
Oslo, Norway Recruiting
Study contacts
- Principal investigator: Kirsten B. Holven, PhD — Oslo University Hospital
- Study coordinator: Kirsten B. Holven, PhD
- Email: kirsten.holven@medisin.uio.no
- Phone: +4722851361
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Fulvic acid supplements for metabolic syndrome
This study tests whether 50 mg or 100 mg of fulvic acid daily for 12 weeks can help people with metabolic syndrome or prediabetes.
-
Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome
This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.
-
Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients
This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.
-
Low-Calorie Diet in adolescents with Familial Mediterranean Fever and metabolic syndrome
A group of adolescents with both FMF and metabolic syndrome will try a low-calorie diet for 3 months to see if it helps manage metabolic symptoms.
-
Exercise for Metabolic Syndrome and Fatty Liver in Adolescent Girls with Celiac Disease
This study tests whether a 3-month walking program helps improve metabolic syndrome and fatty liver in adolescent females with celiac disease.
-
Longevity Metrics AI/ML Development Study
Researchers are testing AI models that score health screening tests and predict outcomes like life expectancy for adults, using ongoing follow-up data.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.